Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 2 EP applications Karen Oestergaard Pedersen has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11779456

DOUBLE-ACYLATED GLP-1 DERIVATIVES

IPC classification:
A61K 47/48, A61P 3/10, C07K 14/605
Applicant:
Novo Nordisk A/S
Agent:
Karen Oestergaard Pedersen, Novo Nordisk A/S
Status:
EXAMINATION IN PROGRESS
EP12805429

GLP-1 DERIVATIVES

IPC classification:
A61K 38/26, C07K 14/605
Applicant:
Novo Nordisk A/S
Agent:
Karen Oestergaard Pedersen, Novo Nordisk A/S
Status:
PATENT GRANTED

Please Sign in to use this feature